Matsuyama H - Search Results

1

Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation.

Hara T, Nishijima J, Miyachika Y, Yamamoto Y, Sakano S, Matsuyama H. Hara T, et al. Among authors: matsuyama h. Jpn J Clin Oncol. 2011 Jul;41(7):902-7. doi: 10.1093/jjco/hyr064. Epub 2011 May 25. Jpn J Clin Oncol. 2011. PMID: 21616918

2

[Angiographic analysis of intratumoral Pt concentration on intra-arterial infusion therapy for bladder cancer].

Matsuyama H, Yamamoto N, Yoshihiro S, Shimabukuro T, Wada T, Sakatoku J. Matsuyama H, et al. Nihon Hinyokika Gakkai Zasshi. 1991 Jul;82(7):1142-9. doi: 10.5980/jpnjurol1989.82.1142. Nihon Hinyokika Gakkai Zasshi. 1991. PMID: 1895628 Free article. Japanese.

3

[Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].

Kurisu H, Shimabukuro T, Wada T, Yamamoto M, Shameem IA, Otsuka T, Sakano S, Matsuyama H, Naito K, Yamamoto N, et al. Kurisu H, et al. Among authors: matsuyama h. Hinyokika Kiyo. 1993 Aug;39(8):715-20. Hinyokika Kiyo. 1993. PMID: 8104387 Free article. Japanese.

4

Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence.

Tsukamoto M, Matsuyama H, Oba K, Yoshihiro S, Takahashi M, Naito K. Tsukamoto M, et al. Among authors: matsuyama h. Cancer Genet Cytogenet. 2002 Apr 1;134(1):41-5. doi: 10.1016/s0165-4608(01)00618-5. Cancer Genet Cytogenet. 2002. PMID: 11996795

5

Metastatic urothelial cancer showing an efficacy by low-dose cisplatin.

Matsuyama H, Yamakawa G, Hirata H. Matsuyama H, et al. Int J Urol. 2002 May;9(5):275-7. doi: 10.1046/j.1442-2042.2002.00465.x. Int J Urol. 2002. PMID: 12060442 Free article.

6

Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.

Matsumoto H, Wada T, Fukunaga K, Yoshihiro S, Matsuyama H, Naito K. Matsumoto H, et al. Among authors: matsuyama h. Jpn J Clin Oncol. 2004 Mar;34(3):124-30. doi: 10.1093/jjco/hyh026. Jpn J Clin Oncol. 2004. PMID: 15078907

7

DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.

Matsuda K, Matsuyama H, Hara T, Yoshihiro S, Oga A, Kawauchi S, Furuya T, Izumi H, Naito K, Sasaki K. Matsuda K, et al. Among authors: matsuyama h. Cancer Genet Cytogenet. 2004 Jul 15;152(2):119-23. doi: 10.1016/j.cancergencyto.2003.11.017. Cancer Genet Cytogenet. 2004. PMID: 15262429

8

Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.

Matsumoto H, Matsuyama H, Fukunaga K, Yoshihiro S, Wada T, Naito K. Matsumoto H, et al. Among authors: matsuyama h. Br J Cancer. 2004 Sep 13;91(6):1025-31. doi: 10.1038/sj.bjc.6602073. Br J Cancer. 2004. PMID: 15292937 Free PMC article.

9

Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.

Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, Kawauchi S, Sasaki K, Naito K. Yamamoto Y, et al. Among authors: matsuyama h. Clin Cancer Res. 2004 Oct 1;10(19):6449-55. doi: 10.1158/1078-0432.CCR-04-0773. Clin Cancer Res. 2004. PMID: 15475431

10

Expression of thymidine phosphorylase in human superficial bladder cancer.

Shimabukuro T, Matsuyama H, Baba Y, Jojima K, Suyama K, Aoki A, Suga A, Yamamoto N, Naito K. Shimabukuro T, et al. Among authors: matsuyama h. Int J Urol. 2005 Jan;12(1):29-34. doi: 10.1111/j.1442-2042.2004.00992.x. Int J Urol. 2005. PMID: 15661051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

747 results

Search Page

Filters